Genmab — Januar 2024
-
they will have a conf call in 30 mins on it , via
- Lundbeck announces supportive phase II results with Lu AF82422 in the treatment of Multiple System Atrophy from the AMULET trial https://news.cision.com/h--lundbeck-a-s/r/lundbeck-announces-supportive-phase-ii-results-with-lu-af82422-in-the-treatment-of-multiple-system-a,c3920120
-
-
-
Jeg er desværre bange for at de er uden for pædagogisk rækkevidde Vitus. Jeg forestiller mig, at bestyrelsen slutter deres møder med spørgsmålet: "aktionærer, hvad er det for noget"? inden de grinende forlader bestyrelseslokalet med lommerne fulde af warrent
-
for B7H4 - Pfizer shuffles its deck post-Seagen https://www.oncologypipeline.com/apexonco/pfizer-shuffles-its-deck-post-seagen
-
Genmab er vel den største, og næsten enestes selvejende institution noteret på C25? Jeg tror vi kan opgive alt om aktietilbagekøb m.m.m. Jeg erindrer, at ATP nærmest blev til grin, da de på en generalforesamling gik imod aflønningsformerne. Så, take it, or leave it. Der kommer aldrig, som i aldrig nogensinde, hverken aktietilbagekøb eller udbytte på banen.Genmab er en. malkeko - men ganske givet ud fra ideologiske synspunkter.
-
Det har så den fordel, at. man ikke behøver at have handelsomkostninger i aktien - den reducer er helt pr. automatik andelen i porteføljen.;-)
-
Novartis Ag (NVS) Q4 2023 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/01/31/novartis-ag-nvs-q4-2023-earnings-call-transcript/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
thx